Treatment with dexamethasone enhanced 3H20 incorporation into liver and blood lipid, and also increased plasma glucose, insulin, non-esterified fatty acid and triacylglycerol concentrations during late gestation in the mother rat. An inverse relationship between glycogen and lipid synthesis in foetal liver and lung was observed in control rats. This relationship was also observed in foetal liver, but not in foetal lung, after treatment with dexamethasone.
Treatment with dexamethasone enhanced 3H20 incorporation into liver and blood lipid, and also increased plasma glucose, insulin, non-esterified fatty acid and triacylglycerol concentrations during late gestation in the mother rat. An inverse relationship between glycogen and lipid synthesis in foetal liver and lung was observed in control rats. This relationship was also observed in foetal liver, but not in foetal lung, after treatment with dexamethasone.
During late gestation, profound changes occur in the concentration of lipid in maternal blood, which may be due to the changes in the rate of lipogenesis de novo observed in those circumstances (Scow et al., 1964; Knoop et al., 1973; Lorenzo et al., 1981) . Since the incorporation of maternal lipid into foetal rat tissues is likely to be secondary to lipogenesis de novo from maternal carbohydrates, the increase in plasma lipid during the second phase of gestation results in more glucose being available for foetal growth. However, the accumulation of glycogen in foetal liver during the last days of gestation (Devos & Hers, 1974 ) may contribute to the decrease in glucose availability for foetal and maternal lipogenesis. Actually, the decrease in lipogenesis in maternal and foetal liver observed during the last 3 days of gestation (Lorenzo et al., 1981) may be concurrent with the increase in glycogen synthesis in foetal liver (Devos & Hers, 1974) .
Treatment with glucocorticoids causes hyperlipidaemia and hyperinsulinaemia in non-pregnant rats. The hyperlipidaemia may be due to the increased lipogenic capacity in the liver as a consequence of the enhancement of the activity of the key enzymes for fatty acid synthesis (Krausz et al., 1981) . On the other hand, treatment with glucocorticoids increases the activity of glycogen synthase, which results in an increase in glycogen content of foetal-rat liver (Eisen et al., 1973; Vanstapel etal., 1980 (1976) . In addition, frozen tissue powder (1 g) was extracted with 3 ml of 6% (w/v) HC104 and centrifuged at 2000g for 15min. Glycogen was precipitated in 2 ml of the HCl04 extract of the tissue at 40C with 4 ml of ethanol. The glycogen pellet was washed, hydrolysed and freeze-dried as described by Postle & Bloxham (1980) . Plasma insulin was measured by radioimmunoassay by the method of , with human insulin as the standard. Non-esterified plasma fatty acids were assayed by the colorimetric method of Itaya & Ui (1965) , and plasma triacylglycerols were extracted and saponified by the method of Eggstein & Kreutz (1966) . Free glycerol was measured by enzymic assay (Garland & Randle, 1962) . Neutralized HCl04 extracts were used for the determination of glucose (Krebs et al., 1963 (Krebs et al., , 1964 .
Results and discussion Rates oflipogenesis in maternal tissues
Treatment with dexamethasone increased the rate of maternal liver lipogenesis and the incorporation of 3H20 into blood lipid at 20, 21 and 22 days of gestation (Table 1) . However, dexamethasone treatment did not affect the inhibition of the rate of hepatic lipogenesis observed during late gestation. At 22 days, this reached values as high as those found at 20 days in control rats (Table 1) .
The enhancement of the rate of hepatic lipogenesis in vivo caused by dexamethasone in pregnant rats (Table 1 ) is in agreement with the reported effects of dexamethasone in virgin rats (Krausz et al., 1981) . These results may account for the significantly higher concentration of plasma triacylglycerol found after dexamethasone treatment as compared with untreated pregnant rats (Table 2) . On the other hand, treatment with dexamethasone increased plasma non-esterified fatty acid concentrations observed between 20 and 22 days of gestation (Table 2) . These results may be explained by a permissive action or potentiating effect of dexamethasone on hormone-induced lipogenesis in adipose tissue as described by Kawai & Kuzuya (1981) . The administration of dexamethasone increased plasma insulin concentration at 20-22 days of gestation ( Table 2) . As a result, a high concentration of plasma insulin was maintained during late gestation. These results seem to support the idea that dexamethasone works on the rate of lipogenesis in vivo in the liver through its capacity to induce insulin secretion by a direct effect on pancreatic cells (Krausz et al., 1981; Svec & Rudis, 1981) . However, the rate of lipogenesis in parametrial adipose tissue was not affected by this treatment (results not shown), which may be due to the marked resistance to insulin observed in rat adipose tissue during late gestation (Costrini & Kalkhoff, 1971; Flint et al., 1979) . The resistance to insulin of adipose tissue may also explain why dexamethasone increased release of non-esterified fatty acids as well as increasing plasma insulin concentrations (Table 2) .
Treatment with dexamethasone enhanced the concentration of plasma glucose observed during the last 3 days of gestation despite the occurrence of hyperinsulinaemia in the same circumstances (Table  2 ). This result may be explained by the decrease in glucose utilization by peripheral tissues caused by the observed rise in plasma non-esterified fatty acids and/or by hepatic gluconeogenesis being stimulated through an activation of regulatory enzymes brought about by glucocorticoid treatment Krausz et al., 1981) . Rates of lipogenesis and glycogen synthesis in foetal tissues The rates of glycogen synthesis in foetal liver were 3-fold higher during days 20 and 21 of gestation as compared with those values in pregnant rats (results not shown), but decreased sharply on day 22 of gestation (Table 1) . These results are in agreement with the storage of glycogen observed in foetal liver during the last 3 days of gestation (Devos & Hers, 1974) . In addition, the rate of glycogen synthesis decreased sharply during the last day of gestation, when glycogenolysis is likely to be stimulated by the initiation of the increase in the plasma glucagon/ insulin ratio observed in the rat at birth (Di Marco et al., 1978; Martin et al., 1981) . Treatment with dexamethasone increased the rate of glycogen synthesis in foetal liver during the last 3 days of gestation, although the profile observed in the absence of treatment remained unchanged (Table 1) . Conversely, the rate of lipogenesis in foetal liver decreased after dexamethasone treatment, as compared with the corresponding day of gestation of control pregnant rats (Table 1) . These results seem to suggest the occurrence of an inverse relationship between lipogenesis and glycogen synthesis in foetalrat liver during late gestation. Actually the increase in the rate of hepatic glycogen synthesis by dexamethasone may result in a decrease in glucose availability for lipogenesis in foetal liver.
The rate of lipogenesis in foetal lung increased during days 20-21 without any change during the last day of gestation (Table 1; Lorenzo et al., 1981) . Conversely, the rate of glycogen synthesis in foetal lung decreased during days 20-21, remaining unchanged during the last day of gestation (Table 1) . Moreover, the decrease in the rate of glycogen synthesis was concurrent with the glycogen depletion that occurred in foetal-rat lung before birth (Maniscalco et al., 1978) , a fact consistent with the suggestion that glycogen depletion provides glucose available for lipid synthesis in the lung (Maniscalco et al., 1978) . Therefore it may be suggested that there is an inverse relationship between glycogen and lipid synthesis in foetal-rat lung during late gestation. Treatment with dexamethasone decreased the rates of both lipogenesis and glycogen synthesis in foetal lung as compared with those values for foetuses from untreated pregnant rats (Table 1) .
This inhibition of synthesis of both glycogen and lipid in the lung might be explained by a decrease in glucose utilization owing to the stimulation of lung lipoprotein lipase activity associated with the effect of corticoids on surfactant synthesis (Mostello et al., 1981) . In addition, the lack of effect of dexamethasone on glycogen synthesis may suggest that glucocorticoids could be ineffective in increasing glycogen synthase activity in foetal lung.
It is noteworthy that treatment with dexamethasone increased maternal, but not foetal, insulinaemia, a fact consistent with the idea that the mechanism for insulin secretion mediated by corticoids has not yet been developed in foetal pancreas (Krausz et al., 1981; Svec & Rudis, 1981) .
In conclusion, our results suggest the occurrence of an inverse relationship between glycogen and lipid synthesis in foetal liver and lung. This relationship was also observed in foetal liver when glycogen synthesis was enhanced by treatment with dexamethasone. On the other hand, treatment with dexamethasone enhanced liver lipogenesis and plasma lipid and glucose concentrations, increasing fuel supply to maternal and foetal tissues. from the 'Foundation R. Areces', Spain. The 'Centro de Biologia Molecular' was the recipient of a grant from 'F.I.S.., Ministerio de Trabajo, Sanidad .y Seguridad Social'.
